asthma

CHENGDU, China – June 9, 2026 Kelun-Biotech has announced that its partner Windward Bio has successfully dosed the first...

CHÂTILLON, France, June 8, 2026 DBV Technologies announced new positive clinical findings from its Phase 3 VITESSE study evaluating...

LONDON, United Kingdom, May 20, 2026 GSK has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved...

SAN FRANCISCO and SUZHOU, China, May 18, 2026 Innovent Biologics presented new clinical and preclinical data from its next-generation...

ORLANDO, Fla., May 19, 2026 Altesa BioSciences announced positive results from its randomized, placebo-controlled Phase 2 rhinovirus challenge study...

SUNRISE, Fla., May 11, 2026 Transpire Bio Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted...

WILMINGTON, Delaware, USA, April 28, 2026 AstraZeneca has announced that its fixed-dose triple-combination therapy Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) has...

Basel, Switzerland | March 27, 2026 Strategic Acquisition Strengthens Allergy Leadership Novartis has announced a major strategic move to...

SAN FRANCISCO & BOSTON, USA | March 24, 2026 Apogee Therapeutics, Inc. has successfully announced the pricing of its...

Cambridge, Massachusetts, USA / Rotterdam, Netherlands / Shanghai, China | March 22, 2026 Harbour BioMed has announced the online...